<DOC>
	<DOCNO>NCT02308059</DOCNO>
	<brief_summary>The current study aim evaluate cross-sectional area ( CSA ) peripheral nerve people diabetic peripheral neuropathy use ultrasonography correlate CSA clinical demographic data .</brief_summary>
	<brief_title>Ultrasonographic Evaluation Diabetic Neuropathy</brief_title>
	<detailed_description>Patients diabetic peripheral neuropathy ( n=53 ) match healthy control group ( n=53 ) underwent blind ultrasonography imaging sciatic , tibial median nerve . Matching perform accord patient body mass index ( BMI ) , sex age . CSAs nerve record , association pain intensity ( measure visual analog scale [ VAS ] ) , Leeds Assessment Neuropathic Symptoms Signs ( LANSS ) pain scale , diabetes mellitus duration , BMI , HbA1c blood glucose level evaluate .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>type 2 diabetes mellitus Leeds Assessment Neuropathic Symptoms Signs ( LANSS ) score â‰¥ 12 probable diabetic peripheral neuropathy accord diabetic peripheral neuropathy criterion . Exclusion Criteria type 1 diabetes mellitus hypothyroidism LANSS pain scale score &lt; 12 body mass index ( BMI ) &gt; 35 current pregnancy history hereditary neuropathy , inflammatory neuropathy , nerve trauma , know cause polyneuropathy ; use antineuropathic drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>